Save your place

Sign in to WhoBought

Please try again later.

Sangamo Therapeutics, Inc. (SGMO) institutional ownership

Market cap$152M SectorHealthcare
Funds holding · Q1 2026
85
reported SGMO position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
54 buyers · 31 sellers

Sangamo Therapeutics, Inc. (SGMO) price and institutional activity

Dates

Q1 2026

$0 bought by 54 investors
Armistice Capital, LLCBalyasny Asset Management L.P. +52 more
$0 sold by 31 investors
Renaissance Technologies LLCTwo Sigma Advisers, LP +29 more
Bought Sold Totals per quarter; hover a bar for the names.

Sangamo Therapeutics, Inc. (SGMO) institutional activity · 85

Investor Type Est. change Change Δ Own Date
Armistice Capital, LLC · New
Change +40.4M Date Q1 2026
Armistice Capital, LLC New· Q1 2026 +40.4M Q1 2026
Balyasny Asset Management L.P. · New
Change +5.3M Date Q1 2026
Balyasny Asset Management L.P. New· Q1 2026 +5.3M Q1 2026
Renaissance Technologies LLC Reduced· Q1 2026 −4.6M −54.5% Q1 2026
Two Sigma Advisers, LP · Exited
Change −4.3M Δ Own −100.0% Date Q1 2026
Two Sigma Advisers, LP Exited· Q1 2026 −4.3M −100.0% Q1 2026
Vanguard · Added
Change +3.2M Date Q1 2026
Vanguard Added· Q1 2026 +3.2M Q1 2026
Jane Street Group, LLC · Exited
Change −2.9M Δ Own −100.0% Date Q1 2026
Jane Street Group, LLC Exited· Q1 2026 −2.9M −100.0% Q1 2026
Bank of America Corp · Added
Change +1.7M Date Q1 2026
Bank of America Corp Added· Q1 2026 +1.7M Q1 2026
UBS Group AG · Added
Change +1.5M Date Q1 2026
UBS Group AG Added· Q1 2026 +1.5M Q1 2026
Two Sigma Investments, LP · Added
Change +1.5M Δ Own +31.8% Date Q1 2026
Two Sigma Investments, LP Added· Q1 2026 +1.5M +31.8% Q1 2026
Wasatch Advisors LP · Exited
Change −1.4M Δ Own −100.0% Date Q1 2026
Wasatch Advisors LP Exited· Q1 2026 −1.4M −100.0% Q1 2026
Jacobs Levy Equity Management, Inc · Added
Change +1000K Date Q1 2026
Jacobs Levy Equity Management, Inc Added· Q1 2026 +1000K Q1 2026
Geode · Added
Change +705K Date Q1 2026
Geode Added· Q1 2026 +705K Q1 2026
Sanders Morris Harris LLC · New
Change +668K Date Q1 2026
Sanders Morris Harris LLC New· Q1 2026 +668K Q1 2026
Schwab · Added
Change +639K Date Q1 2026
Schwab Added· Q1 2026 +639K Q1 2026
Mak Capital One LLC · New
Change +562K Date Q1 2026
Mak Capital One LLC New· Q1 2026 +562K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 85

Famous investor activity in Sangamo Therapeutics, Inc. (SGMO)

Sangamo Therapeutics, Inc. (SGMO) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Davis Gregory D. · Officer Tax withholding or exercise payment (F) -$284
Price $0.17 Qty -2K Owned 114K Trade date May 25, 2026 Filed date May 27, 2026
Davis Gregory D. Officer Tax withholding or exercise payment (F) $0.17 -2K -$284 114K May 25, 2026 May 27, 2026
Jain Nikunj · Officer Tax withholding or exercise payment (F) -$334
Price $0.17 Qty -2K Owned 235K Trade date May 25, 2026 Filed date May 27, 2026
Jain Nikunj Officer Tax withholding or exercise payment (F) $0.17 -2K -$334 235K May 25, 2026 May 27, 2026
Dubois-Stringfellow Nathalie · Officer Tax withholding or exercise payment (F) -$703
Price $0.17 Qty -4K Owned 329K Trade date May 25, 2026 Filed date May 27, 2026
Dubois-Stringfellow Nathalie Officer Tax withholding or exercise payment (F) $0.17 -4K -$703 329K May 25, 2026 May 27, 2026
Willoughby Scott B. · Officer Tax withholding or exercise payment (F) -$703
Price $0.17 Qty -4K Owned 647K Trade date May 25, 2026 Filed date May 27, 2026
Willoughby Scott B. Officer Tax withholding or exercise payment (F) $0.17 -4K -$703 647K May 25, 2026 May 27, 2026
Macrae Sandy · Director Tax withholding or exercise payment (F) -$2K
Price $0.17 Qty -13K Owned 1.9M Trade date May 25, 2026 Filed date May 27, 2026
Macrae Sandy Director Tax withholding or exercise payment (F) $0.17 -13K -$2K 1.9M May 25, 2026 May 27, 2026
Davis Gregory D. · Officer Sell −$18K
Price $0.25 Qty −70K Owned 115K Trade date Apr 22, 2026 Filed date Apr 23, 2026
Davis Gregory D. Officer Sell $0.25 −70K −$18K 115K Apr 22, 2026 Apr 23, 2026
Dubois-Stringfellow Nathalie · Officer Sell −$89K
Price $0.26 Qty −346K Owned 333K Trade date Apr 21, 2026 Filed date Apr 23, 2026
Dubois-Stringfellow Nathalie Officer Sell $0.26 −346K −$89K 333K Apr 21, 2026 Apr 23, 2026
Dubois-Stringfellow Nathalie · Officer Grant (A) 800K
Owned 800K Trade date Apr 1, 2026 Filed date Apr 3, 2026
Dubois-Stringfellow Nathalie Officer Grant (A) 800K 800K Apr 1, 2026 Apr 3, 2026
Jain Nikunj · Officer Grant (A) 225K
Owned 225K Trade date Apr 1, 2026 Filed date Apr 3, 2026
Jain Nikunj Officer Grant (A) 225K 225K Apr 1, 2026 Apr 3, 2026
Davis Gregory D. · Officer Grant (A) 225K
Owned 225K Trade date Apr 1, 2026 Filed date Apr 3, 2026
Davis Gregory D. Officer Grant (A) 225K 225K Apr 1, 2026 Apr 3, 2026
Macrae Sandy · Director Grant (A) 2.5M
Owned 2.5M Trade date Apr 1, 2026 Filed date Apr 3, 2026
Macrae Sandy Director Grant (A) 2.5M 2.5M Apr 1, 2026 Apr 3, 2026
Willoughby Scott B. · Officer Grant (A) 800K
Owned 800K Trade date Apr 1, 2026 Filed date Apr 3, 2026
Willoughby Scott B. Officer Grant (A) 800K 800K Apr 1, 2026 Apr 3, 2026
Dubois-Stringfellow Nathalie · Officer Tax withholding or exercise payment (F) -$6K
Price $0.47 Qty -12K Owned 679K Trade date Feb 25, 2026 Filed date Feb 26, 2026
Dubois-Stringfellow Nathalie Officer Tax withholding or exercise payment (F) $0.47 -12K -$6K 679K Feb 25, 2026 Feb 26, 2026
Macrae Sandy · Director, Officer Tax withholding or exercise payment (F) -$16K
Price $0.47 Qty -34K Owned 1.9M Trade date Feb 25, 2026 Filed date Feb 26, 2026
Macrae Sandy Director, Officer Tax withholding or exercise payment (F) $0.47 -34K -$16K 1.9M Feb 25, 2026 Feb 26, 2026
Willoughby Scott B. · Officer Tax withholding or exercise payment (F) -$6K
Price $0.47 Qty -12K Owned 651K Trade date Feb 25, 2026 Filed date Feb 26, 2026
Willoughby Scott B. Officer Tax withholding or exercise payment (F) $0.47 -12K -$6K 651K Feb 25, 2026 Feb 26, 2026
15 of 45
15 of 45 Sign in to continue to older insider transactions.

Sangamo Therapeutics, Inc. (SGMO) activist and large shareholders

Dates
No Schedule 13D or 13G filing is available for SGMO in this range.

Sangamo Therapeutics, Inc. (SGMO) ownership FAQ

Who owns SGMO?

85 reporting institutions disclosed SGMO position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.